Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.

Cadena, J; Levine, D J; Angel, L F; Maxwell, P R; Brady, R; Sanchez, J F; Michalek, J E; Levine, S M; Restrepo, M I

Cadena, J; Levine, D J; Angel, L F; Maxwell, P R; Brady, R; Sanchez, J F; Michalek, J E; Levine, S M; Restrepo, M I.

Affiliation

Cadena J; Division of Infectious Diseases, Department of Medicine, The University of Texas Health Science Center at San Antonio (UTHSCSA), TX, USA. cadenazuluag@uthscsa.edu

Am J Transplant ; 9(9): 2085-91, 2009 Sep.

Article in En | MEDLINE | ID: mdl-19645709

Subject(s)

Antifungal Agents/therapeutic use; Itraconazole/therapeutic use; Lung Transplantation/methods; Mycoses/complications; Mycoses/prevention & control; Pyrimidines/therapeutic use; Triazoles/therapeutic use; Aged; Cohort Studies; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Treatment Outcome; Voriconazole

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Triazoles / Lung Transplantation / Itraconazole / Mycoses / Antifungal Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google